Tessera Therapeutics

Tessera Therapeutics is a biotechnology company dedicated to developing next-generation genetic tools that go beyond editing to actually write new DNA sequences. By harnessing their proprietary “Gene Writing” platform, they aim to precisely alter the genetic code at its source, enabling the creation of new therapeutic possibilities for a wide range of diseases. Their approach holds the potential to correct underlying genetic errors, expand the horizons of personalized medicine, and fundamentally reshape how we address genetic conditions.